Publications by authors named "Marc Lemann"

Claim this Profile
L
Long-term outcome of enterocutaneous fistula in patients with Crohn's disease treated with anti-TNF therapy: a cohort study from the GETAID.
Aurelien Amiot, Vida Setakhr, Philippe Seksik, Mathieu Allez, Xavier Treton, Marc Lemann

Am J Gastroenterol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of single nucleotide polymorphisms in the region of CLDN2-MORC4 in relation to inflammatory bowel disease.
Jan Söderman, Elisabeth Norén, Malin Christiansson, Hanna Bragde, Raphaele Thiébaut

World J Gastroenterol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotype/phenotype analyses for 53 Crohn's disease associated genetic polymorphisms.
Camille Jung, Jean-Frédéric Colombel, Marc Lemann, Laurent Beaugerie, Matthieu Allez

PLoS One· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol.
Xavier Hébuterne, Marc Lémann, Yoram Bouhnik, Olivier Dewit, Jean-Louis Dupas

Gut· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges to the design, execution, and analysis of randomized controlled trials for inflammatory bowel disease.
Geert D'Haens, Brian Feagan, Jean-Frédéric Colombel, William J Sandborn, Walter Reinisch

Gastroenterology· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.
David Laharie, Arnaud Bourreille, Julien Branche, Matthieu Allez, Yoram Bouhnik

Lancet· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical predictors at diagnosis of disabling pediatric Crohn's disease.
Guillaume Savoye, Julia Salleron, Corinne Gower-Rousseau, Jean-Louis Dupas, Gwénola Vernier-Massouille, Marc Lemann

Inflamm Bowel Dis· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS).
Simon P L Travis, Dan Schnell, Piotr Krzeski, Maria T Abreu, Douglas G Altman

Gut· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High frequency of fatal haemophagocytic lymphohistiocytosis syndrome in enteropathy-associated T cell lymphoma.
Aurelien Amiot, Matthieu Allez, Xavier Treton, Claire Fieschi, Lionel Galicier

Dig Liver Dis· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped.
Edouard Louis, Jean-Yves Mary, Gwenola Vernier-Massouille, Jean-Charles Grimaud, Yoram Bouhnik, Marc Lemann

Gastroenterology· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report.
Brian G Feagan, Marc Lémann, Ragnar Befrits, William Connell, Geert D'Haens

Inflamm Bowel Dis· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.
Laurent Peyrin-Biroulet, Kiarash Khosrotehrani, Fabrice Carrat, Anne-Marie Bouvier, Jean-Baptiste Chevaux

Gastroenterology· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing patients' satisfaction with anti-TNFα treatment in Crohn's disease: qualitative steps of the development of a new questionnaire.
Claire Marant, Benoit Arnould, Alexia Marrel, Céderic Spizak, Jean-Frédéric Colombel, Marc Lemann

Clin Exp Gastroenterol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: a population-based study.
Valérie Crombé, Julia Salleron, Guillaume Savoye, Jean-Louis Dupas, Gwénola Vernier-Massouille

Inflamm Bowel Dis· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crohn's disease recurrence after total proctocolectomy with definitive ileostomy.
Aurélien Amiot, Jean-Marc Gornet, Clotilde Baudry, Nicolas Munoz-Bongrand, Martine Auger

Dig Liver Dis· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of the receptor NKG2D leads to production of Th17 cytokines in CD4+ T cells of patients with Crohn's disease.
Benjamin Pariente, Iulia Mocan, Matthieu Camus, Charles-Antoine Dutertre, Julien Ettersperger

Gastroenterology· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of the Crohn's disease digestive damage score, the Lémann score.
Benjamin Pariente, Jacques Cosnes, Silvio Danese, William J Sandborn, Maïté Lewin

Inflamm Bowel Dis· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNF alpha antagonist therapy and safety monitoring.
Thao Pham, Hervé Bachelez, Jean-Marie Berthelot, Jacques Blacher, Yoram Bouhnik, Marc Lemann

Joint Bone Spine· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.
Carl A Anderson, Gabrielle Boucher, Charlie W Lees, Andre Franke, Mauro D'Amato

Nat Genet· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study.
Jessica Coelho, Laurent Beaugerie, Jean Frédéric Colombel, Xavier Hébuterne, Eric Lerebours

Gut· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting the need for colectomy in severe ulcerative colitis: a critical appraisal of clinical parameters and currently available biomarkers.
Simon Travis, Jack Satsangi, Marc Lémann

Gut· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease.
Yukihide Momozawa, Myriam Mni, Kayo Nakamura, Wouter Coppieters, Sven Almer

Nat Genet· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.
Andre Franke, Dermot P B McGovern, Jeffrey C Barrett, Kai Wang, Graham L Radford-Smith, Marc Lemann

Nat Genet· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects.
Matthieu Allez, Konstantinos Karmiris, Edouard Louis, Gert Van Assche, Shomron Ben-Horin

J Crohns Colitis· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Appropriate maintenance treatment for Crohn's disease: Results of a multidisciplinary international expert panel - EPACT II.
Pascal Juillerat, John-Paul Vader, Christian Felley, Valérie Pittet, Jean-Jacques Gonvers

J Crohns Colitis· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis